BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 23911408)

  • 1. CD4+CD25+ T regs with acetylated FoxP3 are associated with immune suppression in human leprosy.
    Kumar S; Naqvi RA; Ali R; Rani R; Khanna N; Rao DN
    Mol Immunol; 2013 Dec; 56(4):513-20. PubMed ID: 23911408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxP3 provides competitive fitness to CD4⁺CD25⁺ T cells in leprosy patients via transcriptional regulation.
    Kumar S; Naqvi RA; Ali R; Rani R; Khanna N; Rao DN
    Eur J Immunol; 2014 Feb; 44(2):431-9. PubMed ID: 24214631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Th17 cytokines in leprosy: correlation with circulating CD4(+) CD25 (high)FoxP3 (+) T-regs cells, as well as down regulatory cytokines.
    Attia EA; Abdallah M; El-Khateeb E; Saad AA; Lotfi RA; Abdallah M; El-Shennawy D
    Arch Dermatol Res; 2014 Nov; 306(9):793-801. PubMed ID: 25018055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
    Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
    Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Th1/Th2 and macrophage lineage cytokines in leprosy; correlation with circulating CD4(+) CD25(high) FoxP3(+) T-regs cells.
    Abdallah M; Attia EA; Saad AA; El-Khateeb EA; Lotfi RA; Abdallah M; El-Shennawy D
    Exp Dermatol; 2014 Oct; 23(10):742-7. PubMed ID: 25109693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating CD4+ CD25 high FoxP3+ T cells vary in different clinical forms of leprosy.
    Attia EA; Abdallah M; Saad AA; Afifi A; El Tabbakh A; El-Shennawy D; Ali HB
    Int J Dermatol; 2010 Oct; 49(10):1152-8. PubMed ID: 20883403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
    Longhi MS; Meda F; Wang P; Samyn M; Mieli-Vergani G; Vergani D; Ma Y
    Hepatology; 2008 Feb; 47(2):581-91. PubMed ID: 18220288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4
    Tarique M; Naqvi RA; Ali R; Khanna N; Rao DN
    Exp Dermatol; 2017 Oct; 26(10):946-948. PubMed ID: 28109171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis.
    Xu G; Mou Z; Jiang H; Cheng L; Shi J; Xu R; Oh Y; Li H
    Laryngoscope; 2007 May; 117(5):876-80. PubMed ID: 17473687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive nuclear localization of NFAT in Foxp3+ regulatory T cells independent of calcineurin activity.
    Li Q; Shakya A; Guo X; Zhang H; Tantin D; Jensen PE; Chen X
    J Immunol; 2012 May; 188(9):4268-77. PubMed ID: 22490438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other.
    Horwitz DA; Zheng SG; Gray JD
    Trends Immunol; 2008 Sep; 29(9):429-35. PubMed ID: 18676178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
    Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
    Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.
    Miyara M; Yoshioka Y; Kitoh A; Shima T; Wing K; Niwa A; Parizot C; Taflin C; Heike T; Valeyre D; Mathian A; Nakahata T; Yamaguchi T; Nomura T; Ono M; Amoura Z; Gorochov G; Sakaguchi S
    Immunity; 2009 Jun; 30(6):899-911. PubMed ID: 19464196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
    Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
    Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.